Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FA0DA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,054
Award facts
- Contract value 100% obligated
- $51,054.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections, with a contract ceiling value of $51,054.15. This firm fixed-price delivery order, which must be completed by November 18, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the contractor to furnish a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems. The company's existing contract portfolio demonstrates extensive experience supplying specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic areas. The Zepbound delivery order reflects the contractor's ongoing role in providing diabetes and metabolic disorder treatments to support military healthcare operations. As a child contract under the larger IDC vehicle, this award leverages AmerisourceBergen's established capabilities and federal supply chain infrastructure to meet military pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DR26FA0DA?
SPE2DR26FA0DA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FA0DA worth?
The government has obligated $51,054 on SPE2DR26FA0DA.
Is contract SPE2DR26FA0DA an order under another contract?
Yes. SPE2DR26FA0DA is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0DA competed?
The extent of competition for SPE2DR26FA0DA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award